Insider · CIK 0001829079
Catherine E Woteki
Files at NEOG (NEOGEN CORP). First filing Apr 25, 2025, latest Apr 25, 2025.
In brief
Catherine E Woteki files SEC Form 4 as director at NEOG (NEOGEN CORP). Since Apr 25, 2025, Catherine E Woteki has reported 1 open-market buy worth $30k and 0 open-market sells worth $0, the latest filed on Apr 25, 2025.
A track record needs three past buys with six months of prices behind them; Catherine E Woteki has 0, so none is measured yet.
The newest scored trade: bought $30k of NEOG on Apr 25, 2025, filed Apr 25, 2025, scored 53 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NEOG: NEOGEN CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | NEOGEN CORP | $30k 5,770 shares | +77% | +18% from low-71% from high |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | NEOG NEOGEN CORP | AGrant or award Restricted Stock Units | +9,804 | $12.24 | $120k | 28,921 | 12 d ago |
| Oct 1, 2026 | NEOG NEOGEN CORP | AGrant or award Common Stock (Right to Buy)derivative | +20,558 | $0.00 | $0 | 20,558 | 12 d ago |
| Oct 27, 2025 | NEOG NEOGEN CORP | MOption exercise Common Stock | +1,777 | $6.19 | $11k | 19,117 | Oct 28, 2025 |
| Oct 27, 2025 | NEOG NEOGEN CORP | MOption exercise Restricted Stock Unitsderivative | -1,777 | $6.19 | $11k | 1,777 | Oct 28, 2025 |
| Oct 23, 2025 | NEOG NEOGEN CORP | AGrant or award Common Stock | +19,769 | $6.07 | $120k | 35,084 | Oct 27, 2025 |
| Oct 23, 2025 | NEOG NEOGEN CORP | AGrant or award Common Stock (Right to Buy)derivative | +50,814 | $0.00 | $0 | 50,814 | Oct 27, 2025 |
| Oct 7, 2025 | NEOG NEOGEN CORP | MOption exercise Common Stock | +2,071 | $5.63 | $12k | 15,315 | Oct 9, 2025 |
| Oct 7, 2025 | NEOG NEOGEN CORP | MOption exercise Restricted Stock Unitsderivative | -2,071 | $5.63 | $12k | 0 | Oct 9, 2025 |
| Apr 25, 2025 | NEOG NEOGEN CORP | POpen-market purchase Common Stock | +5,770 | $5.17 | $30k | 13,244 | Apr 25, 2025 |
| Oct 28, 2024 | NEOG NEOGEN CORP | MOption exercise Common Stock | +1,776 | $13.81 | $25k | 7,474 | Oct 29, 2024 |
| Oct 28, 2024 | NEOG NEOGEN CORP | MOption exercise Restricted Stock Unitsderivative | -1,776 | $13.81 | $25k | 3,552 | Oct 29, 2024 |
| Oct 24, 2024 | NEOG NEOGEN CORP | AGrant or award Restricted Stock Units | +6,075 | $13.58 | $82k | 17,397 | Oct 28, 2024 |
| Oct 24, 2024 | NEOG NEOGEN CORP | AGrant or award Common Stock (Right to Buy)derivative | +18,653 | $0.00 | $0 | 18,653 | Oct 28, 2024 |
| Oct 26, 2023 | NEOG NEOGEN CORP | MOption exercise Common Stock (Right to Buy)derivative | +13,716 | $0.00 | $0 | 38,883 | Oct 31, 2023 |
| Oct 26, 2023 | NEOG NEOGEN CORP | MOption exercise Restricted Stock Unitsderivative | +5,329 | $0.00 | $0 | 9,706 | Oct 31, 2023 |
Questions about Catherine E Woteki
Answered from the filings on this page, as of the latest one.
Is Catherine E Woteki buying or selling?
Not in the last 12 months. Catherine E Woteki's latest open-market trade on SEC Form 4 was bought $30k of NEOG on Apr 25, 2025.
How did Catherine E Woteki's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Catherine E Woteki has 0.
Where does Catherine E Woteki file Form 4?
Catherine E Woteki has filed Form 4 at NEOG (NEOGEN CORP). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.